127 related articles for article (PubMed ID: 3539308)
1. Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance.
Natali PG; Roberts JT; Difilippo F; Bigotti A; Dent PB; Ferrone S; Liao SK
Cancer; 1987 Jan; 59(1):55-63. PubMed ID: 3539308
[TBL] [Abstract][Full Text] [Related]
2. Detection of a human melanoma-associated antigen, p97, in histological sections of primary human melanomas.
Garrigues HJ; Tilgen W; Hellstróm I; Franke W; Hellström KE
Int J Cancer; 1982 May; 29(5):511-5. PubMed ID: 7095896
[TBL] [Abstract][Full Text] [Related]
3. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
4. Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.
Thompson JJ; Herlyn MF; Elder DE; Clark WH; Steplewski Z; Koprowski H
Am J Pathol; 1982 Jun; 107(3):357-61. PubMed ID: 6177248
[TBL] [Abstract][Full Text] [Related]
5. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
[TBL] [Abstract][Full Text] [Related]
8. Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma.
Giacomini P; Veglia F; Cordiali Fei P; Rehle T; Natali PG; Ferrone S
Cancer Res; 1984 Mar; 44(3):1281-7. PubMed ID: 6692408
[TBL] [Abstract][Full Text] [Related]
9. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors.
Wick MR; Swanson PE; Rocamora A
J Cutan Pathol; 1988 Aug; 15(4):201-7. PubMed ID: 3053811
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors.
Atkinson B; Ernst CS; Ghrist BF; Ross AH; Clark WH; Herlyn M; Herlyn D; Maul G; Steplewski Z; Koprowski H
Hybridoma; 1985; 4(3):243-55. PubMed ID: 4043988
[TBL] [Abstract][Full Text] [Related]
11. The differential reactivity of benign and malignant nevomelanocytic lesions with mouse monoclonal antibody TNKH1.
Nakanishi T; Hashimoto K
Cancer; 1987 Apr; 59(7):1340-4. PubMed ID: 3545436
[TBL] [Abstract][Full Text] [Related]
12. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
13. A 94,000-dalton glycoprotein expressed by human melanoma and carcinoma cells.
Imai K; Wilson BS; Bigotti A; Natali PG; Ferrone S
J Natl Cancer Inst; 1982 May; 68(5):761-9. PubMed ID: 6951087
[TBL] [Abstract][Full Text] [Related]
14. Human melanoma-associated antigens: analysis of antigenic heterogeneity by molecular, serologic and flow-cytometric approaches.
Morgan AC; Woodhouse C; Bartholemew R; Schroff R
Mol Immunol; 1986 Feb; 23(2):193-200. PubMed ID: 2422545
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of antimelanoma monoclonal antibodies, with special reference to fetal tissue distribution.
Kageshita T; Johno M; Ono T; Arao T; Imai K
J Invest Dermatol; 1985 Dec; 85(6):535-7. PubMed ID: 3905976
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues.
Brown JP; Woodbury RG; Hart CE; Hellström I; Hellström KE
Proc Natl Acad Sci U S A; 1981 Jan; 78(1):539-43. PubMed ID: 6165996
[TBL] [Abstract][Full Text] [Related]
17. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
Mirecka J; Korabiowska M; Schauer A
Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
[TBL] [Abstract][Full Text] [Related]
18. Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma.
Hollinshead AC
Cancer; 1975 Oct; 36(4):1282-8. PubMed ID: 51680
[TBL] [Abstract][Full Text] [Related]
19. Antigenic profiles of individual-matched pairs of primary and melanoma metastases.
Meije CB; Swart GW; Lepoole C; Das PK; Van den Oord JJ
Hum Pathol; 2009 Oct; 40(10):1399-407. PubMed ID: 19386352
[TBL] [Abstract][Full Text] [Related]
20. S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain.
Kindblom LG; Lodding P; Rosengren L; Baudier J; Haglid K
Acta Pathol Microbiol Immunol Scand A; 1984 Jul; 92(4):219-30. PubMed ID: 6496075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]